Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries India Globalization Capital Inc (NY: IGC ) 0.3690 -0.0063 (-1.68%) Official Closing Price Updated: 8:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 680,442 Open 0.3899 Bid (Size) 0.3700 (7) Ask (Size) 0.3757 (54) Prev. Close 0.3753 Today's Range 0.3518 - 0.3899 52wk Range 0.2501 - 0.9099 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Preclinical Research Evaluating New Molecule IGC-1C in Treatment of Alzheimer’s Disease August 22, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease August 22, 2024 From IGC Pharma, Inc. Via Business Wire Performance YTD +33.70% +33.70% 1 Month -18.02% -18.02% 3 Month -26.20% -26.20% 6 Month +5.73% +5.73% 1 Year +17.52% +17.52% More News Read More InvestorNewsBreaks – IGC Pharma Inc.’s (NYSE American: IGC) AI-Driven Approach Reveals ‘Promising Opportunity’ for IGC-1A to Be a Potential GLP-1 Agonist August 20, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist August 20, 2024 From IGC Pharma Via Business Wire IGC Stock Earnings: IGC Pharma Beats EPS, Misses Revenue for Q1 2025 August 12, 2024 Via InvestorPlace BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Releases Q1 2025 Financial, Operational Results Report August 09, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research August 09, 2024 Via Benzinga IGC Pharma Reports First Quarter Fiscal 2025 Results August 08, 2024 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Receives ‘Buy’ Recommendation in AGP’s Analyst Coverage Research Report July 18, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target July 18, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc.’s (NYSE American: IGC) TGR-63 Demonstrates Blood-Brain Barrier Permeability in Preliminary Findings July 09, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile July 09, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Releases Positive Data from TGR-63 Preclinical Studies June 26, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Financial Report for Fiscal Year June 25, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease June 25, 2024 From IGC Pharma, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Via InvestorPlace IGC Stock Earnings: IGC Pharma Meets EPS, Beats Revenue for Q4 2024 June 24, 2024 Via InvestorPlace IGC Reports Financial Results for Fiscal Year Ended March 31, 2024 June 24, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Execs Slated to Present at Upcoming Ascendiant Capital Markets Event June 18, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets June 18, 2024 From IGC Pharma, Inc. Via Business Wire Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected June 13, 2024 Via Benzinga Topics Cannabis Regulatory Compliance Exposures Cannabis Legal Regulatory 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Publication of Key Study in European Journal June 10, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol June 10, 2024 From IGC Pharma, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session June 04, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.